C
Chiara Bocelli-Tyndall
Researcher at University Hospital of Basel
Publications - 22
Citations - 2507
Chiara Bocelli-Tyndall is an academic researcher from University Hospital of Basel. The author has contributed to research in topics: Mesenchymal stem cell & Transplantation. The author has an hindex of 19, co-authored 22 publications receiving 2328 citations. Previous affiliations of Chiara Bocelli-Tyndall include University of Basel.
Papers
More filters
Journal ArticleDOI
Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database
Ulrich A. Walker,A Tyndall,L. Czirják,Christopher P. Denton,Dominique Farge-Bancel,Otylia Kowal-Bielecka,Ulf Müller-Ladner,Chiara Bocelli-Tyndall,Marco Matucci-Cerinic +8 more
TL;DR: The clinical distinction seemed to be superseded by an antibody-based classification in predicting some scleroderma complications, and the EUSTAR MEDS database facilitates the analysis of clinical patterns in SSc, and contributes to the standardised assessment and monitoring of SSc internationally.
Journal ArticleDOI
Autologous stem cell transplantation in the treatment of systemic sclerosis: Report from the EBMT/EULAR Registry
Dominique Farge,Jakob Passweg,J.M. van Laar,Zora Marjanovic,C. Besenthal,Jürgen Finke,Hans-Hartmut Peter,Ferdinand C. Breedveld,Willem E. Fibbe,Carol M. Black,Christopher P. Denton,I. Koetter,Francesco Locatelli,Alberto Martini,Anton Schattenberg,F.H.J. van den Hoogen,L. B. A. Van De Putte,Francesco Lanza,Renate Arnold,P. A. Bacon,Sarah J. Bingham,Fabio Ciceri,B. Didier,José Luis Díez-Martín,Paul Emery,W. Feremans,Bernd Hertenstein,Falk Hiepe,R. Luosujarvi,A. Leon Lara,Alberto M. Marmont,Angelina Martínez,H. Pascual Cascon,Chiara Bocelli-Tyndall,Eliane Gluckman,Alois Gratwohl,A Tyndall +36 more
TL;DR: It was shown that response in two thirds of the patients after HSCT was durable with an acceptable TRM and prospective, randomised trials are proceeding.
Journal ArticleDOI
Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database.
Riccardo Saccardi,Tomas Kozak,Chiara Bocelli-Tyndall,A Fassas,Aristidis Kazis,Eva Havrdova,Enric Carreras,Albert Saiz,Bob Löwenberg,P Aw te Boekhorst,Francesca Gualandi,Harry Openshaw,G Longo,F Pagliai,Luca Massacesi,E Deconink,J Ouyang,F Jz Nagore,Juan Besalduch,I. Lisukov,A Bonini,Elisa Merelli,Shimon Slavin,Alois Gratwohl,Jakob Passweg,Alan Tyndall,Andreas J. Steck,M Andolina,Marco Capobianco,J Ld Martin,Alessandra Lugaresi,Giuseppe Meucci,Ricardo Saez,Richard E. Clark,Mario Fernandez,L. Fouillard,B. Herstenstein,Vladimir Koza,Eleonora Cocco,H Baurmann,G. L. Mancardi +40 more
TL;DR: HSCT was shown as a promising procedure to slow down progression in a subset of patients affected by severe, progressive MS; the safety and feasibility of the procedure can be significantly improved by appropriate patient selection and choice of transplant regimen.
Journal ArticleDOI
Autologous hematopoietic stem cell transplantation for autoimmune diseases.
Alois Gratwohl,Jakob Passweg,Chiara Bocelli-Tyndall,A Fassas,J.M. van Laar,Dominique Farge,M Andolina,Renate Arnold,Enric Carreras,Jürgen Finke,Ina Kötter,Tomas Kozak,I. Lisukov,Bob Löwenberg,Alberto M. Marmont,John Moore,Riccardo Saccardi,John A. Snowden,F.H.J. van den Hoogen,NM Wulffraat,X. Zhao,Alan Tyndall +21 more
TL;DR: Data from the collective EBMT experience support the hypothesis that autologous HSCT can alter disease progression in severe autoimmune disease.
Journal ArticleDOI
Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005
Alan Tyndall,Ulrich A. Walker,Andrew P. Cope,Francesco Dazzi,Cosimo De Bari,Willem E. Fibbe,Serena Guiducci,Simon Jones,Christian Jorgensen,Katarina Le Blanc,Frank P. Luyten,Dennis McGonagle,Ivan Martin,Chiara Bocelli-Tyndall,Giuseppina Pennesi,Vito Pistoia,Constantino Pitzalis,Antonio Uccelli,Nico M Wulffraat,Marc Feldmann +19 more
TL;DR: This review summarizes the findings of a 1-day meeting devoted to the subject with the aim of coordinating efforts and shows that animal models of autoimmune disease treated with multipotent mesenchymal stromal cells have mostly exhibited a positive clinical response.